PML nuclear bodies: from architecture to function

被引:168
|
作者
Lallemand-Breitenbach, Valerie [1 ,2 ,3 ]
de The, Hugues [1 ,2 ,3 ,4 ]
机构
[1] INSERM, U944, Equipe Labellise Ligue Natl Canc, CNRS,UMR 7212, Paris, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, Hop St Louis, 1 Ave Claude Vellefaux, F-75475 Paris 10, France
[3] PSL Res Univ, Coll France, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France
[4] Hop St Louis, AP HP, Serv Biochim, Paris, France
关键词
PROMYELOCYTIC LEUKEMIA PROTEIN; OXIDATIVE STRESS; UBIQUITIN LIGASE; RAR-ALPHA; PREMATURE SENESCENCE; CHROMATIN-STRUCTURE; MISFOLDED PROTEINS; ARSENIC TRIOXIDE; ONCOGENIC RAS; HUMAN-CELLS;
D O I
10.1016/j.ceb.2018.03.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
PML nuclear bodies are nucleated by the PML protein, which polymerizes into spherical shells where it concentrates many unrelated partner proteins. Emerging data has connected PML bodies to post-translational control, notably conjugation by SUMOs. High concentrations of SUMO-bound proteins were proposed to condense into liquid-like droplets and such phase transition may occur within NBs. Many stress pathways modulate NB formation and recent findings have directly implicated PML in oxidative stress response in vivo. PML may also undergo SUMO-dependent ubiquitination/degradation. We highlight recent advances linking PML to partner degradation and other adaptative post-translational modifications in the context of chromatin remodeling, telomere biology, senescence or viral infections.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 50 条
  • [41] Role and fate of PML nuclear bodies in response to interferon and viral infections
    Tarik Regad
    Mounira K Chelbi-Alix
    Oncogene, 2001, 20 : 7274 - 7286
  • [42] Regulation of E2Fs and senescence by PML nuclear bodies
    Vernier, Mathieu
    Bourdeau, Veronique
    Gaumont-Leclerc, Marie-France
    Moiseeva, Olga
    Begin, Virginie
    Saad, Fred
    Mes-Masson, Anne-Marie
    Ferbeyre, Gerardo
    GENES & DEVELOPMENT, 2011, 25 (01) : 41 - 50
  • [43] Cellular radiation sensitivity and regulation of PML nuclear bodies after radiation
    Mörtel, H
    Distel, L
    Fritsch, M
    Georgi, JC
    Eyrich, W
    Grabenbauer, G
    Sauer, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 101 - 101
  • [44] PML NUCLEAR BODIES AND OTHER TRIM-DEFINED SUBCELLULAR COMPARTMENTS
    Batty, Elizabeth C.
    Jensen, Kirsten
    Freemont, Paul S.
    TRIM/RBCC PROTEINS, 2012, 770 : 39 - 58
  • [45] PML nuclear bodies and chromatin dynamics: catch me if you can!
    Corpet, Armelle
    Kleijwegt, Constance
    Roubille, Simon
    Juillard, Franceline
    Jacquet, Karine
    Texier, Pascale
    Lomonte, Patrick
    NUCLEIC ACIDS RESEARCH, 2020, 48 (21) : 11890 - 11912
  • [46] PML nuclear bodies: dynamic sensors of DNA damage and cellular stress
    Dellaire, G
    Bazett-Jones, DP
    BIOESSAYS, 2004, 26 (09) : 963 - 977
  • [47] Role and fate of PML nuclear bodies in response to interferon and viral infections
    Regad, T
    Chelbi-Alix, MK
    ONCOGENE, 2001, 20 (49) : 7274 - 7286
  • [48] Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies
    Hirano, Seishiro
    Udagawa, Osamu
    PLOS ONE, 2022, 17 (05):
  • [49] Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies
    Tavalai, Nina
    Stamminger, Thomas
    VIRUSES-BASEL, 2009, 1 (03): : 1240 - 1264
  • [50] Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL
    Shao, Xuejing
    Chen, Yingqian
    Xu, Aixiao
    Xiang, Danyan
    Wang, Wei
    Du, Wenxin
    Huang, Yunpeng
    Zhang, Xingya
    Cai, Minyi
    Xia, Zhimei
    Wang, Yi
    Cao, Ji
    Zhang, Yan
    Yang, Bo
    He, Qiaojun
    Ying, Meidan
    CELL DEATH AND DIFFERENTIATION, 2022, 29 (08): : 1654 - 1668